News | July 15, 2022
Evonik now offers enteric protected ready to fill capsules EUDRACAP in IPEC-GMP quality
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions
Aflibercept is the second biosimilar product that has entered the clinical trial phase after biosimilar Adalimumab
Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & Director & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
Subscribe To Our Newsletter & Stay Updated
